Healthcare evaluation of the use of atosiban and fibronectin for the management of pre-term labour

Journal of Obstetrics and Gynaecology

Volumn 29, Issue 6, 2009, Pages 507-511

  Siassakos, D ^a   O'Brien, K ^a   Draycott, T ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

Atosiban; Cost; Fibronectin; Pre term; Tocolysis

Indexed keywords

ATOSIBAN; FIBRONECTIN; NIFEDIPINE;

ARTICLE; CLINICAL PROTOCOL; COST CONTROL; DRUG EFFICACY; DRUG SAFETY; FEMALE; FETUS DISTRESS; HEART FAILURE; HUMAN; LOW BIRTH WEIGHT; LUNG EDEMA; NAUSEA; PREMATURE LABOR; PRIORITY JOURNAL; TOCOLYSIS; VOMITING;

DECISION TREES; FEMALE; FIBRONECTINS; HEALTH SERVICES RESEARCH; HUMANS; NIFEDIPINE; OBSTETRIC LABOR, PREMATURE; PREGNANCY; TOCOLYTIC AGENTS; VASOTOCIN;

EID: 69349092068     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.1080/01443610903003191     Document Type: Article

References (36)

1. Afschar P, Scholl W, Bader A, Bauer M, Winter R. 2004. A prospective randomised trial of atosiban versus hexoprenaline for acute tocolysis and intrauterine resuscitation. British Journal of Obstetrics and Gynaecology 111:316-318. (Pubitemid 38446105)
2. Al-Omari WR, Al-Shammaa HB, Al-Tikriti EM, Ahmed KW. 2006. Atosiban and nifedipine in acute tocolysis: a comparative study. European Journal of Obstetrics, Gynecology, and Reproductive Biology 128:129-134. (Pubitemid 44335862)
3. British Medical Association and Royal Pharmaceutical Society of Great Britain. 2007. British National Formulary (BNF) 54. London: British Medical Journal Publishing Group Ltd and RPS Publishing.
4. Brown MA, Buddle ML, Farrell T, Davis GK. 2002. Efficacy and safety of nifedipine tablets for the acute treatment of severe hypertension in pregnancy. American Journal of Obstetrics and Gynecology 187:1046-1050. (Pubitemid 35178409)
5. Chandiramani M, Shennan A. 2006. Pre-term labour: update on prediction and prevention strategies. Current Opinion in Obstetrics and Gynecology 18:618-624. (Pubitemid 44747178)
6. Goodwin TM, Paul R, Silver H, Spellacy W, Parsons M, Chez R et al. 1994. The effect of the oxytocin antagonist atosiban on pre-term uterine activity in the human. American Journal of Obstetrics and Gynecology 170:474-478. (Pubitemid 24089002)
7. Grobman WA, Welshman EE, Calhoun EA. 2004. Does fetal fibronectin use in the diagnosis of pre-term labor affect physician behavior and healthcare costs? A randomized trial. American Journal of Obstetrics and Gynecology 191:235-240.
8. Hofmeyr G, Kulier R. 1998. Operative versus conservative management for 'fetal distress' in labour [Electronic Version]. Cochrane Database of Systematic Reviews, Issue 2. Available at: www.cochrane.org/reviews/en/ab001065.html (Accessed 7 September 2007).
9. Iams JD. 2003. Prediction and early detection of pre-term labor. Obstetrics and Gynecology 101:402-412.
10. Impey L. 1993. Severe hypotension and fetal distress following sublingual administration of nifedipine to a patient with severe pregnancy induced hypertension at 33 weeks. British Journal of Obstetrics and Gynaecology 100:959-961. (Pubitemid 23308289)
11. Joint Formulary Committee. 2007. British National Formulary. 54th ed. London: British Medical Association and Royal Pharmaceutical Society of Great Britain. Available at: http://www.bnf.org/bnf (Accessed 7 September 2007).
12. Kashanian M, Akbarian AR, Soltanzadeh M. 2005. Atosiban and nifedipine for the treatment of pre-term labour. International Journal of Gynaecology and Obstetrics 91:10-14.
13. King JF. 2004. Tocolysis and pre-term labour. Current Opinion in Obstetrics and Gynecology 16:459-463.
14. King JF, Flenady V, Papatsonis D, Dekker G, Carbonne B. 2003. Calcium channel blockers for inhibiting pre-term labour; a systematic review of the evidence and a protocol for administration of nifedipine. Australian and New Zealand Journal of Obstetrics and Gynaecology 43:192-198. (Pubitemid 36790188)
15. King JF, Flenady VJ, Papatsonis DN, Dekker GA, Carbonne B. 2002. Calcium channel blockers for inhibiting pre-term labour. Cochrane Database of Systematic Reviews 2:CD002255.
16. Leitich H, Kaider A. 2003. Fetal fibronectin - how useful is it in the prediction of pre-term birth? British Journal of Obstetrics and Gynaecology 110:66-70.
17. Lowe MP, Zimmerman B, Hansen W. 2004. Prospective randomized controlled trial of fetal fibronectin on pre-term labor management in a tertiary care center. American Journal of Obstetrics and Gynecology 190:358-362. (Pubitemid 38249229)
18. Maxwell RJ. 1984. Quality assessment in health. British Medical Journal (Clinical Research ed.) 288:1470-1472.
19. Moutquin JM, Sherman D, Cohen H, Mohide PT, Hochner-Celnikier D, Fejgin M et al. 2000. Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of pre-term labor: a multicenter effectiveness and safety study. American Journal of Obstetrics and Gynecology 182:1191-1199. (Pubitemid 30353310)
20. Papatsonis D, Flenady V, Cole S, Liley H. 2005. Oxytocin receptor antagonists for inhibiting pre-term labour. Cochrane Database of Systematic Reviews 3:CD004452.
21. Petrou S, Glazener C. 2002. The economic costs of alternative modes of delivery during the first two months postpartum: results from a Scottish observational study. British Journal of Obstetrics and Gynaecology 109:214-217. (Pubitemid 37338048)
22. Plaut M. 1996. Fetal fibronectin and the safety of outpatient management of pre-term labor symptoms. American Journal of Obstetrics and Gynecology 174:797-798. (Pubitemid 26070183)
23. Plaut MM, Smith W, Kennedy K. 2003. Fetal fibronectin: the impact of a rapid test on the treatment of women with pre-term labor symptoms. American Journal of Obstetrics and Gynecology 188:1588-1595. (Pubitemid 36741291)
24. Revah A, Hannah ME, Sue AQ. A. K. 1998. Fetal fibronectin as a predictor of pre-term birth: an overview. American Journal of Perinatology 15:613-621.
25. Romero R, Sibai BM, Sanchez-Ramos L, Valenzuela GJ, Veille JC, Tabor B et al. 2000. An oxytocin receptor antagonist (atosiban) in the treatment of pre-term labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue. American Journal of Obstetrics and Gynecology 182:1173-1183. (Pubitemid 30353308)
26. Shim JY, Park YW, Yoon BH, Cho YK, Yang JH, Lee Y et al. 2006. Multicentre, parallel group, randomised, single-blind study of the safety and efficacy of atosiban versus ritodrine in the treatment of acute pre-term labour in Korean women. British Journal of Obstetrics and Gynaecology 113:1228-1234. (Pubitemid 44581510)
27. Steer PJ. 2006. The epidemiology of pre-term labour - why have advances not equated to reduced incidence? British Journal of Obstetrics and Gynaecology 113:1-3.
28. Tan TC, Devendra K, Tan LK, Tan HK. 2006. Tocolytic treatment for the management of pre-term labour: a systematic review. Singapore Medical Journal 47:361-366.
29. Terzidou V, Bennett PR. 2002. Pre-term labour. Current Opinion in Obstetrics and Gynecology 14:105-113.
30. The Worldwide Atosiban versus Beta-agonists Study Group. 2001. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of pre-term labour. British Journal of Obstetrics and Gynaecology 108:133-142.
31. Valenzuela GJ, Sanchez-Ramos L, Romero R, Silver HM, Koltun WD, Millar L et al. 2000. Maintenance treatment of pre-term labor with the oxytocin antagonist atosiban. The Atosiban PTL-098 Study Group. American Journal of Obstetrics and Gynecology 182:1184-1190.
32. van Geijn HP, Lenglet JE, Bolte AC. 2005. Nifedipine trials: effectiveness and safety aspects. British Journal of Obstetrics and Gynaecology 112:79-83.
33. van Veen AJ, Pelinck MJ, van Pampus MG, Erwich JJ. 2005. Severe hypotension and fetal death due to tocolysis with nifedipine. British Journal of Obstetrics and Gynaecology 112:509-510. (Pubitemid 40516571)
34. Vojcek L, Princzkel E, Lampe LG, Turnbull AC, Kovacs T. 1988. Effects of calcium channel-blocker tokolysis on the foetal circulation. Acta Physiologica Hungarica 71:517-528. (Pubitemid 18162085)
35. Wood NS, Costeloe K, Gibson AT, Hennessy EM, Marlow N, Wilkinson AR. 2003. The EPICure study: growth and associated problems in children born at 25 weeks of gestational age or less. Archives of Disease in Childhood. Fetal and Neonatal Edition 88:F492-F500. (Pubitemid 37449424)
36. Wood NS, Costeloe K, Gibson AT, Hennessy EM, Marlow N, Wilkinson AR. 2005. The EPICure study: associations and antecedents of neurological and developmental disability at 30 months of age following extremely pre-term birth. Archives of Disease in Childhood. (Fetal and Neonatal ed.) 90:F134-F140.